AVITHRAPID Seminar Series: Advancing European Collaboration on Broad-Spectrum Antivirals
On May 19, 2025, AVITHRAPID held the second event in its official seminar series, strengthening ties with a key Horizon Europe sibling initiative: the NAVIPP Consortium (New Antivirals Against Infections with Pandemic Potential). This encounter reflects a shared vision—to accelerate the discovery and development of broad-spectrum antiviral solutions to better prepare Europe for future epidemic […]
Halicin: A Dual-Action Molecule Against COVID-19 – New Findings from AVITHRAPID
AVITHRAPID scientists uncover how a repurposed antibiotic disrupts the core of the coronavirus replication machinery – opening new doors for broad-spectrum antiviral development. A Strategic Target: The Viral Protease 3CLpro SARS-CoV-2, the virus behind COVID-19, uses a specific enzyme, the 3C-like protease (3CLpro), to process its polyproteins. After infecting a cell, the virus synthesizes large […]
AVITHRAPID at INF-ACT Conference
The partners of AVITHRAPID strive to disseminate project activities during key scientific events, both at local and international level. High-profile conferences are pivotal opportunities to meet academia and industries and confront with state-of-the-art research in AVITHRAPID-related topics. This INF-ACT conference, held in Naples on April 3rd-5th, offered a broad and important opportunity for networking to […]
AVITHRAPID project meets HERA
On 3 March 2025, the AVITHRAPID consortium met HERA during the first AVITHRAPID seminar to foster collaboration and explore new opportunities in the domain of antivirals as response against pandemic infectious diseases. During the online meeting, Prof. Bjoern Windshuegel and Prof. Vincenzo Summa of the Consortium led the introduction of activities and services of AVITHRAPID […]
AVITHRAPID Launches ‘AVITHRAPID SEMINARS’ to Advance Pandemic Preparedness and Antiviral Research
AVITHRAPID, the cutting-edge European initiative dedicated to accelerating antiviral research and pandemic preparedness, is proud to announce the launch of AVITHRAPID SEMINARS—a dynamic series of expert-driven discussions uniting regulatory authorities, pharmaceutical industry leaders, European projects, and key stakeholders. The first closed-door seminar is scheduled for Monday, March 3, 2025, featuring a high-level discussion with HERA […]
Workshop ” Biology and Applications of Extracellular Vesicles”
On Wednesday 12 February 2025, a workshop entitled “Biology and Applications of Extracellular Vesicles” was held in the Aula Magna “Carlo Perone Pacifico”, of the Department of Agricultural and Forestry Sciences, University of Tuscia, partner of Avithrapid consortium. It was organized by Professors Umberto Bernabucci and Nicola Lacetera, as Scientific Directors, respectively, of the PRIN […]
AVITHRAPID Joins Bluesky: A New Space to Connect with the Scientific Community
AVITHRAPID is a project designed to tackle global challenges in antiviral research through an innovative and multidisciplinary approach. Our vision extends beyond laboratory work and scientific publications—we believe in fostering connections, engaging with the scientific community, and sharing our work with a wider audience. For this reason, we are pleased to announce our official presence […]
The ARCA Factory event
Francesca Incardona of EuResist network, member of Avithrapid consortium, was in Bologna to explore international collaborations at a 2 days workshop for infectious diseases specialists and virologists: the ARCA (Antiretroviral Resistance Cohort Analysis) Factory event (Bologna 30 Sept-1 October).ARCA Factory (https://www.informapro.it/arca.html) is one of the educational events organised by ARCA (http://www.hivARCA.net) a large HIV Italian […]
7th Innovative Approaches for Antiviral Agents Summer School (IAAASS)
Innovative Approaches for Antiviral Agents Summer School: A Platform for Knowledge Sharing and Future Discovery From September 23rd to 27th, 2024, the Innovative Approaches for Antiviral Agents Summer School (IAAASS) brought together early-career researchers and internationally recognized experts to review and discuss the latest advanced techniques in antiviral drug discovery. This unique event, designed to […]
European Researchers’ Night in Frascati, Italy
Science at Your Fingertips: The Significance of the European Researchers’ Night in Frascati On October 2, 2024, Avithrapid was introduced to the scientific community and the public during the European Researchers’ Night in Frascati, Rome. This event, part of the Science Week that began on September 21st, featured a multitude of activities across partner cities […]